Predictive value of less than moderate residual mitral regurgitation as assessed by transesophageal echocardiography for the short-term outcomes of patients with mitral regurgitation treated with mitral valve repair

Table 1 Baseline characteristics.

Variables	Group 1 (n = 54)	Group 2 (n = 44)	P value
Age, years	62.3 ± 11.5	66.6 ± 10.5	0.11
Women, n (%)	19 (35)	18 (41)	0.56
Weight, kg	73.4 ± 14.7	68.9 ± 13.7	0.13
Height, cm	172.1 ± 9.0	168.9 ± 8.9	0.07
Body mass index, kg/m²	24.9 ± 3.9	24.0 ± 3.4	0.40
Current smoker, n (%)	10 (19)	7 (16)	0.73
Diabetes mellitus, n (%)	15 (28)	11 (25)	0.76
Hyperlipidemia, n (%)	22 (41)	17(39)	0.83
Arterial hypertension, n (%)	22 (41)	24 (55)	0.17
Ejection fraction, %	57.9 ± 9.4	55.3 ± 8.3	0.13
NYHA 3/4, n (%)	30 (56)	31 (70)	0.20
COPD, n (%)	9 (17)	6 (14)	0.68
Other concomitant diseases, n (%)	13 (19)	10 (16)	0.88

NYHA-New York Heart Association (classification). COPD-chronic obstructive pulmonary disease. Group 1-no residual mitral regurgitation. Group 2-less than moderate mitral regurgitation.

ISSN: 1476-7120